Literature DB >> 34209467

Role of Multiple Comorbidities and Therapies in Conditioning the Clinical Severity of DRESS: A Mono-Center Retrospective Study of 25 Cases.

Andrea Toniato1, Chiara Gamba1, Jan Walter Schroeder1, Valeria Fabbri1, Scarlett Valeria Bernal Ortiz1, Linda Borgonovo1, Marta Piantanida1, Joseph Scibilia1, Luca Balossi1, Eleonora Brusamolino1, Emanuela Bonoldi2, Valentina Caputo2, Michele Nichelatti3, Elide Anna Pastorello1.   

Abstract

DRESS/DiHS is a complex and potentially fatal drug reaction. Little is known about risk factors and elements that can help to identify patients with a severe reaction early. The aim of the study was to investigate those factors favoring the disease and its severity by analyzing the clinical conditions and therapies preceding the reaction. We conducted a retrospective analysis on patients admitted to our center between 2010 and 2020 who were discharged with a diagnosis of DRESS. We used the RegiSCAR diagnostic criteria. We defined the severity of DRESS using the criteria of Mizukawa et al. We included 25 patients (15 females) with a median age of 66 years. Skin involvement, eosinophilia, and liver injury were the most important aspects. Allopurinol was found to be the most involved drug. Reaction severity was significantly associated with the number of daily medications (p=0.0067) and an age of at least 68 years (p=0.013). In addition, 75% of severe cases had at least three comorbidities in history, and most of the severe cases were female. In our study the advanced age, the high number of comorbidities and home therapies, and the inflammatory state were found to be predisposing elements to the development of the disease and its severity.

Entities:  

Keywords:  DRESS syndrome; SCAR; comorbidities; drug reaction with eosinophilia and systemic symptoms; drug-induced hypersensitivity syndrome; risk factors; severity

Year:  2021        PMID: 34209467     DOI: 10.3390/ijms22137072

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  2 in total

1.  A definite case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) induced by administration of the Pfizer/BioNTech BNT162b2 vaccine for SARS-CoV2.

Authors:  Jan Walter Schroeder; Chiara Gamba; Andrea Toniato; Franco Rongioletti
Journal:  Clin Dermatol       Date:  2022-05-10       Impact factor: 2.797

2.  Current Understanding of Immunological Skin Diseases: Atopic Dermatitis, Generalized Anhidrosis, and Drug Hypersensitivity.

Authors:  Hideo Hashizume
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.